These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11488365)

  • 21. Relationships between changes in symptom ratings, neurophysiological test performance and quality of life in schizophrenic patients treated with clozapine.
    Galletly CA; Clark CR; McFarlane AC; Weber DL
    Psychiatry Res; 1997 Oct; 72(3):161-6. PubMed ID: 9406905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
    Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
    Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia.
    Umbricht DS; Wirshing WC; Wirshing DA; McMeniman M; Schooler NR; Marder SR; Kane JM
    J Clin Psychiatry; 2002 May; 63(5):420-4. PubMed ID: 12019667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia.
    Howanitz E; Pardo M; Smelson DA; Engelhart C; Eisenstein N; Stern RG; Losonczy MF
    J Clin Psychiatry; 1999 Jan; 60(1):41-4. PubMed ID: 10074877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient.
    Berecz R; Glaub T; Kellermann M; de la Rubia A; Llerena A; Degrell I
    Pharmacopsychiatry; 2000 Jan; 33(1):42-4. PubMed ID: 10721883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clozapine and treatment of negative symptoms].
    Lançon C; Farisse J; Llorca PM
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
    Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
    Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine plus lamotrigine in treatment-resistant schizophrenia.
    Dursun SM; McIntosh D; Milliken H
    Arch Gen Psychiatry; 1999 Oct; 56(10):950. PubMed ID: 10530638
    [No Abstract]   [Full Text] [Related]  

  • 30. Clozapine: efficacy and safety.
    Buchanan RW
    Schizophr Bull; 1995; 21(4):579-91. PubMed ID: 8749886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agents.
    Spivak B; Musin E; Mester R; Gonen N; Talmon Y; Guy N; Roitman S; Kupchik M; Kotler M; Weizman A
    Int Clin Psychopharmacol; 1999 Jul; 14(4):229-32. PubMed ID: 10468315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.
    Krakowski MI; Czobor P; Nolan KA
    J Clin Psychopharmacol; 2008 Oct; 28(5):485-93. PubMed ID: 18794642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs.
    Wetter TC; Lauer CJ; Gillich G; Pollmächer T
    J Psychiatr Res; 1996; 30(6):411-9. PubMed ID: 9023785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placebo-controlled trial of glycine added to clozapine in schizophrenia.
    Evins AE; Fitzgerald SM; Wine L; Rosselli R; Goff DC
    Am J Psychiatry; 2000 May; 157(5):826-8. PubMed ID: 10784481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
    [No Abstract]   [Full Text] [Related]  

  • 37. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
    Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozapine: current status and role in the pharmacotherapy of schizophrenia.
    Remington GJ; Addington D; Collins EJ; Jones BD; Lalonde P; MacCrimmon DJ; MacEwan GW
    Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.
    Henderson DC; Goff DC
    J Clin Psychiatry; 1996 Sep; 57(9):395-7. PubMed ID: 9746446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Weight gain and clozapine].
    Jalenques I; Tauveron I; Albuisson E; Audy V
    Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.